News search

    E.g., 20/02/2025
    E.g., 20/02/2025
    About the CNIC
    12 Dec 2019
    Jacob Fog Bentzon receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis

    Professor Jacob Fog Bentzon from Aarhus University and the CNIC  receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world
    Primera fila: Irene Fernández-Nueda, Marta Cortés-Canteli, Valentín Fuster, Ana Marcos-Díaz y Borja Ibáñez. Detrás: Javier Sánchez-González, Carlos Cerón y Sergio Callejas.
    Research
    9 Oct 2019
    JACC: An oral anticoagulant delays the appearance of Alzheimer disease in mice

    Treatment of mice for 12 months with the anticoagulant drug dabigatran prevented memory loss and preserved cerebral circulation

    Rocío Sierra, José María Fernández-Toro, Cristina Clavería, Raquel Justo-Méndez, José Antonio Enríquez, Ana Victoria Lechuga-Vieco y Luis Miguel Criado.
    Research
    4 Oct 2019
    Cell Metabolism: CNIC scientists discover a new mechanism for the transfer of maternal genetic material

    CNIC researchers have defined the dynamics of  the transfer of mitochondrial DNA from mothers to their offspring
    About the CNIC
    18 Sep 2019
    A CNIC researcher awarded two projects of the European Diabetes Society

    Dra. Ivana Nikolić studies the role of T cells in the development of diseases associated with obesity
    Atrial electroanatomic map of a pig with persistent AFib. The regions colored magenta, purple, and dark blue have high mean FM values. These regions maintain the AFib, and their ablation with a catheter stops the arrhythmia. The squares represent the sites of rotational activity, which are sensitive but not specific to the regions that maintain the fibrillation.
    Research
    12 Sep 2019
    Circulation Research: A new method to improve treatment of atrial fibrillation

    The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research

    From left to right: Marta Román, Fernando Domínguez, Laura Padrón-Barthe, Pablo Garcia-Pavia, Giovanna Giovinazzo, Enrique Lara-Pezzi, Demetrio J. Santiago, Javier Larrasa-Alonso
    Research
    5 Sep 2019
    Circulation: Possible treatment breakthrough for the rare disease arrhythmogenic right ventricular cardiomyopathy type 5

    Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease
    SRSF3 expression in adult cardiomyocytes. Pink staining shows SRSF3 expression in cell nuclei, which are stained blue. Green staining shows the presence of troponin, a sarcomere protein expressed in cardiomyocytes.
    Research
    4 Jul 2019
    Circulation Research: CNIC scientists identify an essential protein for correct heart contraction and survival

    A new study published in Circulation Research shows that loss of cardiac expression of SRSF3 leads to a critical reduction in the expression of genes related to contraction
    About the CNIC
    12 Jun 2019
    Dr. Miguel Torres elected a member of the European Molecular Biology Organization – EMBO

    EMBO promotes excellence in scientific research, and one of its major goals is to support talented researchers at all stages of their careers
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Photo
    Research
    8 Jan 2019
    Circulation: Expression of a molecule in blood cells predicts atherosclerosis risk

    The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors